👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

US stocks fall as tech stumbles ahead of Fed meeting

Published 2024-12-16, 07:22 p/m
© Reuters
US500
-
DJI
-
GOOGL
-
AAPL
-
AMZN
-
ESH25
-
1YMH25
-
NQH25
-
AVGO
-
IXIC
-

Investing.com-- US stocks fell Tuesday, as tech took a breather from its recent gains as investors rein bullish bets stocks just ahed of the last Federal Reserve meeting of the year.  

At 12:58 ET (17:58 GMT), the Dow Jones Industrial Average fell 259 points, or 0.6%, the S&P 500 index dropped 0.4%, and the NASDAQ Composite slipped  0.3%.  

Retail sales surprise to upside ahead of Fed meeting

Retail sales rose by 0.7% in November, above the 0.6% forecast, underscores that the US economy is still growing at a healthy pace even with higher interest rates.

The central bank is widely expected to cut interest rates by 25 basis points at the conclusion of a two-day meeting on Wednesday.

While a rate cut appears to be largely priced in by markets, especially considering recent gains in Wall Street, focus will be chiefly on the central bank’s outlook on rates.

Investors are bracing for the Fed to signal a slower pace of easing in 2025 amid growing signs of sticky inflation and strength in the labor market- two major points of contention for the Fed.

Goldman Sachs (NYSE:GS) analysts said in a recent note that they no longer expect a rate cut in January, and that the bank will cut rates by a slightly slower pace in the coming year. 

Traders were seen pricing in a 81.9% chance the Fed will leave rates unchanged in January, CME Fedwatch showed. 

Tech sector struggles after recent melt up as Nvidia falls deeper into correction

Tech took a breather Tuesday as NVIDIA Corporation (NASDAQ:NVDA) dropped 1% to fall deeper into correction territory following the chipmaker's 10% slump from its more recent high. 

Tesla Inc (NASDAQ:TSLA), meanwhile, sidestepped the broader weakness after Mizuho (NYSE:MFG) upgraded the EV maker to outperform and hiked its price target on the stock to $515 from $230, citing a boost from loosening regulations .

Pfizer (NYSE:PFE) stock rose 4.3% after the drugmaker said it was expecting its 2025 profits to be nearly in line with expectations, with the company reining in costs and cutting debt by shedding non-core businesses as its rebuilds itself post a sharp slump in sales of COVID-19 products.

Crypto stocks jump as bitcoin continues rally

Crypto-focused stocks continued to rally, including Coinbase Global (NASDAQ:COIN) and MicroStrategy (NASDAQ:MSTR), as bitcoin surpassed $107,000. 

(Peter Nurse, Ambar Warrick contributed to this article.)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.